FROM:
Description
Destiny Pharma is a clinical phase biotechnology company dedicated to infection prevention. The company has two late stage clinical programmes and an earlier preclinical pipeline. The strategy is to build strong clinical data packages and then seek partners for the final clinical studies and commercialisation.
READ MORE >
Company Snapshot
Status
Not Live
Price
3.00
Ticker
DEST
Class
ORD
Settlement
CREST
Industry
Professional, scientific & technical services
COUNTRY
United Kingdom
Company Number
03167025
ISIN
GB00BDHSP575
Currency
GBX
COMPANY INSIGHTS
Incorporated
4 March 1996
Securities in Issue
95.77m
Market Cap
£2.87m
key features of trading on jp jenkins
BUYERS
Buyers decide on the price per share they’re willing to pay, and the number of shares they wish to buy.
SELLERS
Sellers decide the minimum price they’ll accept for their shares.
IMPORTANT INFORMATION
This instruments from Destiny Pharma Limited (Suspended) is not traded on an investment exchange such as the London Stock Exchange or the Alternative Investment Market. Consequently, transactions involving these instruments may be infrequent, potentially causing a delay between when you give instructions to buy or sell and when your order is executed. Additionally, it can be challenging to accurately assess the value of your investment.
Description
Destiny Pharma is a clinical phase biotechnology company dedicated to infection prevention. The company has two late stage clinical programmes and an earlier preclinical pipeline. The strategy is to build strong clinical data packages and then seek partners for the final clinical studies and commercialisation.
READ MORE >
Latest News
SEE MORE NEWS ARTICLES >
Destiny Pharma Limited (Suspended) Management Information
Sir Nigel Rudd
Chairman
Chris Tovey
Chief Executive Officer
Dr William Love
Founder and Chief Scientific Officer
Shaun Claydon
Chief Financial Officer and Company Secretary
Dr Debra Barker
Senior Independent Director and Interim CMO
James Stearns
Non-Executive Director
Aled Williams
Non-Executive Director
Nigel Brooksby
Non-Executive Director
Destiny Pharma Limited (Suspended) Contact Details
Address
Unit 36 Sussex Innovation Centre Science Park Square,
Falmer,
Brighton,
BN1 9SB
Falmer,
Brighton,
BN1 9SB
phone
01273 704440
Contacts
Contact Destiny Pharma
https://destinypharma.com/contact/
Registrar
Link Market Services Limited
Central Square
10th Floor
29 Wellington Street
Leeds
LS1 4DL
Central Square
10th Floor
29 Wellington Street
Leeds
LS1 4DL
TRANSACTING ON JP JENKINS
‘Trading‘ on JP Jenkins is done via a matched bargain facility, this means that on instruction from your ‘Broker’ we will endeavour to match your shares against other buyer(s) or seller(s) who are also looking to transact. Requests to trade are performed on an availability basis, should an instruction be cancelled, altered or amended in anyway by an instruction from your broker then it shall lose its active place in the queue and reset to the end of list. JP Jenkins receives orders from brokers electronically via a FIX message or should your broker not have a FIX connection to our platform via telephone. If you do not have a UK registered stockbroker you will find a list of brokers that we have worked with to download here. You will also find a list of UK brokers at the bottom of this page and their contact details should you need to appoint one. JP Jenkins can ONLY take instruction to transact from a UK-registered stockbroker and cannot offer investment advice into companies displayed on our website. If you are unsure about trading please consult a financial advisor or wealth manager to assist you in determining what is right for you
